| Dr Matthew A Hrastich, DO | |
|
1125 Madison St, Jefferson City, MO 65101-5227 | |
| (573) 632-5263 | |
| Not Available |
| Full Name | Dr Matthew A Hrastich |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 1125 Madison St, Jefferson City, Missouri |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669453866 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 2005032731 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Deaconess Hospital Inc | Evansville, IN | Hospital |
| St Louis University Hospital | Saint louis, MO | Hospital |
| Good Samaritan Hospital | Vincennes, IN | Hospital |
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| Ssm St Clare Health Center | Fenton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Health Care Group | 0143608372 | 678 |
| Ernst Radiology Clinic, Inc | 2961488366 | 18 |
| Evansville Radiology Pc | 6406826031 | 26 |
| Ernst Radiology Clinic, Inc | 2961488366 | 18 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
| Entity Name | Ernst Radiology Clinic, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629000971 PECOS PAC ID: 2961488366 Enrollment ID: O20040626000181 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
| Entity Name | Capital Region Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477980837 PECOS PAC ID: 4688573686 Enrollment ID: O20070323000507 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
| Entity Name | Usa Radiology Management Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689091076 PECOS PAC ID: 3577780337 Enrollment ID: O20141024001746 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
| Entity Name | Evansville Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891782983 PECOS PAC ID: 6406826031 Enrollment ID: O20180502002870 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
| Entity Name | Ernst Radiology Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699425462 PECOS PAC ID: 2264829639 Enrollment ID: O20220602002306 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew A Hrastich, DO Po Box 1128, Jefferson City, MO 65102-1128 Ph: (573) 632-5263 | Dr Matthew A Hrastich, DO 1125 Madison St, Jefferson City, MO 65101-5227 Ph: (573) 632-5263 |
News Archive
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Secretary of State Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. and five other countries - Canada, Sweden, Mexico, Ghana and Bangladesh - to cut pollutants that contribute to global warming, the Washington Post reports.
"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
› Verified 2 days ago
Dr. E. Dwain Roberts, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-556-7755 Fax: 573-761-3599 | |
Dr. Bonnie R Smith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-556-7755 Fax: 573-761-3599 | |
Donald K Mcnutt, D.O. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2713 Industrial Dr, Suite C, Jefferson City, MO 65109 Phone: 573-634-7884 Fax: 573-634-3146 | |
Dr. Jeffrey P. Patrick, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-556-7755 Fax: 573-761-3599 | |
Denzil J. Hawes-davis, D.O. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-635-7141 Fax: 573-634-3146 | |
Dr. Steven C. Harper, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-556-7755 Fax: 573-761-3599 | |
Mitchell Teruichi Godbee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5265 Fax: 573-632-5948 |